Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

Inclusion Criteria: * Patients with breast cancer referred to Physical Therapy for CIPN * Physical Therapy Examination indicates use of Rebuilder for CIPN * At least 18 years of age * Signed informed consent for study population * Willingness to complete study according to protocol Exclusion Criteria: * Patients who do not have CIPN * Patients \<18 years of age * Inability to or unwilling to sign informed consent * Unable to read and understand the English language * Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism * More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy